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Abstract: 
A novel series of phthalazine derivatives bearing isoindol-1,3-dione moiety were synthesized by treating 2-[4-(4-
chlorophthalazine-1-yl)phenyl]-1H-isoindole-1,3-(2H)-dione 3 with various chemical reagents.The newly 
synthesi- zed compounds were characterized on the basis of their spectral (
1
H NMR, 
13
C NMR, Ms, IR) analyses. 
In vitro, most of the synthesized derivatives were screened for their antitumor activity against HepG2 cells using 
MTT assay. Compounds 11, 18 and 19c showed the most potent cytotoxic effect concluded from their IC50 
values 217.4, 240.3 and 234.5 µg/ml respectively. 
Key Words: Phthalazin-1-(2H)-One; chlorophthalazine; isoindol-1,3-dione;  antitumor activity. 
 
1. Introduction:  
Nitrogen-containing heterocycles possesses diverse chemotherapeutic activities [1,2]. Among a large 
variety of nitrogen-containing heterocyclic compounds, phthalazin-1(2H)-ones, they were reported to be used as 
efficient antitumors [3] and therapeutic agents [4].
 
N-(4-Chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-
amine, also known as Vatalanib has been shown to serve as anticancer agent (Fig.1). 
On the other hand, phthalazinones bearing a substituent at C-4 represent key intermediates in the 
synthesis of various compounds with highly interesting clinical applications and pharmacological properties, 
such as anti-heart disease [5], blood platelet aggregation inhibitors and cardiovascular antihypertensive agents 
[6-13]. 
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Fig. 1 Structures of Vatalanib and Azamerone. 
 
Furthermore, meroterpenoid Azamerone, isolated from the saline culture of a new marine-derived 
bacterium related to the genus Streptomyces represents example of this unique phthalazinone ring system as a 
natural product (Fig.1). 
In addition, a number phthalazinone derivatives are well known to be active as potential anticonvulsant [14], 
cardiotonic[15], vasorelaxant [16], also used as anticancer agents and antitumor activity [17].  
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In view of the above mentioned facts and in continuation of our research interest for the synthesis of 
biologically active heterocycles [18-20], we report here, the synthesis of novel series of phthalazinones bearing 
isoindol-1,3-dione moiety followed by evaluation of their antitumor activities against HepG2 cells using MTT 
Cell Viability.  
 
2. Results and Discussion:  
 Synthesis of 2-[4-(4-oxo-3,4-dihydrophthalazin-1-yl)phenyl]-1H-isoindo- le-1,3-(2H)-dione 2 required 
as starting material was accomplished in high yield by fusion of phthalic anhydride with 4-(4-aminophenyl)-
phthalazin-1- (2H)- one 1 (prepared from the reaction of γ-keto acids with hydrazine hydrate in ethanol [21-23]) 
(Scheme 1) .The structure of phthalazinone 2 was elucidated on the basis of spectral studies. 
1
H NMR spectrum 
showed signal at δ 7.99 ppm corresponding to NH proton, 13.20 corresponding to OH proton exchangeable with 
D2O, 7.40-7.93 ppm(m,12H, aromatic protons). Also, IR spectrum displayed absorption bands at ύ 3208-3085 
cm
-1
, 1746 – 1700 cm
-1
, 1685 cm
-1
 due to NH↔OH, CO imidic, CO amidic, respectively. (Scheme 1)  
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Scheme 1 
Treatment of phthalazinone 2 with phosphorus pentachloride and phosphorus oxychloride afforded 2-
[4-(4-chlorophthalazin-1-yl)phenyl]-1H- isoindole-1,3(2H)-dione 3 which is used as a reactive key precursor for 
the synthesis of phthalazine series and their fused derivatives.  
Thus, the reaction of chlorophthalazine 3 with sodium methoxide furnish- ed 2-[4-(4-
methoxyphthalazine-1-yl)-phenyl]isoindole-1,3-dione 4.However, treatment of chlorophthalazine 3 with sodium 
azide in DMSO afforded tetrazolo phthalazine 5, spectral data and elemental analysis confirmed the proposed 
structures.On the other hand, the reaction of chlorophthalazine 3 with ethanolamine in dioxane gave product 6 
which in turn reacted with SOCl2 in benzene to give phthalazinium chloride 7. The corresponding free base 8 
was formed by treating of compound 7 with 15% K2CO3 solution. Furthermore, reaction of chlorophthalazine 3 
with thiourea in sodium ethoxide afforded phthalazine derivative 9. (Scheme 2) 
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            Formation of phthalazine 9 possibly proceeded according to mechanism described in Fig.2. 
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Fig. 2 Mechanism of the formation of compound 9 
            Also, refluxing of chlorophthalazine 3 with benzoylhydrazine in butanol furnished 2-[4-(3-phenyl-
[1,2,4]triazolo[3,4-a]phthalazine-6-yl)-phenyl]-iso- indole-1,3-dione 10. The reactivity of chlorophthalazine 
towards amino acids was also investigated .Thus; treatment of chlorophthalazine 3 with glycine in the presence 
of pyridine gave acid derivative 11.
 1
H NMR of acid 11 showed signals at 12.8 and 8.3 corresponding to OH and 
NH, respectively, singlet at 2.5 ppm corresponding to CH2. However, the latter compound underwent ring 
closure by refluxing with acetic anhydride to afford 2-[4-(3-oxo-2,3-dihydro-imidazo[2,1-a ]phthalazine-6-yl)-
phenyl]-isoindole-1,3-dione 12. (Scheme 3) 
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Scheme 3 
 On the other hand, anthranilic acid reacted with chlorophthalazine 3 to give tetracyclic system 13. 
Whereas, m-amino benzoic acid and p-amino benzoic acid reacted with chlorophthalazine under the same 
reaction conditions to afford aminophthalazine derivatives 14a,b respectively. Also, chlorophthalazine 3 was 
refluxed with aromatic amines such as o-phenylenediamine, p-phenylene diamine, o-aminophenol and p-
aminophenol in benzene to afford phthalazine derivatives 15a-d respectively. On the other hand, compounds 15a 
and 15c underwent thermal cyclization to furnish imidazophthalazine derivative 16. (Scheme 4).  
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Scheme 4 
However, reaction of chlorophthalazine 3 with ammonium thiocyanate lead to formation of 17 which in 
turn reacted with ethyl isocyanate in dry acetone to give 2-[4-(2-ethyl-1-oxo-3-thioxo-2,3-dihydro-1H-
2,4,10,10a-tetraza- phenanthren-9-yl)-phenyl]-isoindole-1,3-dione 18. Reactivity of chlorophthal- azine 3 
towards primary amines namely, benzylamine, p-amino benzophenone and hydrazine hydrate in n-butanol 
afforded products 19a-c, respectively. (Scheme 5). 
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Scheme 5 
 Furthermore, boiling of hydrazide 19c with acetic acid afforded imidazophthalazine derivative 20. 
Finally, refluxing of 19c with benzaldehyde in butanol lead to the formation of benzylidene hydrazone 21. 
(Scheme 5) 
 
3. Experimental protocols  
3.1 Chemistry  
  All chemicals and solvents were of high analytical grade and were purchased from Sigma Chemical 
Company and all melting points were determined on Gallen Kamp and are uncorrected. IR spectra were 
measured with a Pye-Unicam spectrophotometer type 1200, using potassium bromide disk; results are given in 
cm
-1
. Varian spectrometer was utilized for 
1
H NMR spectra with TMS as internal reference and in the solvent 
DMSO-d6. The chemical shifts are reported of frequency = 300 MHz (ppm) downfield from internal 
tetramethylsilane (TMS) and coupling constants (J) are given in Hz. Electron impact MS spectra were obtained 
on a Mat-711 spectrometer inlet temperature Ca, 200°C instrument at 70/eV. 
3.1.1. Synthesis of 4-(4-Aminophenyl)phthalazin-1-(2H)-one (1)  
To a solution of 2-(4-amino-benzoyl)-benzoic acid (2.37 gm,10 mmol) in absolute ethanol 15 mL, (12 gm, 240 
mmol) was added hydrazine hydrate and the reaction mixture was refluxed for 6 h [21-23]. After cooling, the 
precipitated was filtered off and crystallized from dimethylformamide/ water to give brown crystals. 
M.p. 250-252 °C; yield 50 %; IR (cm
-1
) ν: 3295-3064 (NH2,NH↔OH) ,1685 (CO); Ms: m/z 237 (M·+); 
1
H 
NMR (DMSO-d6) δ: 5.31 (s, 2H, NH2 exchangeable),7.99 (s,1H, NH↔OH exchangeable), 6.50-8.19 (m, 8H, Ar-H); 
Anal. Calcd.for C14H11N3O (Mol.wt.237): C, 70.87; H, 4.67; N, 17.71; Found: C, 70.85; H, 4.69; N, 17.70%.  
3.1.2. 2-[4-(4-Oxo-3,4-dihydrophthalazin-1-yl)-phenyl]-isoindole-1,3-dione(2)  
A mixture of 1 (2.37 gm,10 mmol) and phthalic anhydride (1.48 gm,10 mmol) is heated at 250
°
C for 2 hrs , after 
cooling , the residue was triturated with H2O and the solid that obtained was filtered off and recrystallized from 
ethanol to give yellow crystals. 
M.p. 305-307 °C; yield 93 %; IR (cm
-1
): 3490-3208 (NH↔OH), 1746-1700 (CO),1590 (C=N); Ms: m/z 367 
(M
·+
); 
1
H NMR (DMSO-d6) δ: 8.17 (s, 1H, NH exchangeable), 7.69-8.19 (m, 12H, Ar-H); Anal. Calcd. For 
C22H13O3N3 (Mol.wt.367): C, 71.93; H, 3.57; N, 11.44, Found: C, 71.83; H, 3.60; N 11.40%. 
3.1.3. 2-[4-(4-Chlorophthalazin-1-yl)-phenyl]-isoindole-1,3-dione (3) 
A mixture of phthalazinone 2 (3.67 gm,10 mmol), phosphorus penta- chloride (2.8 gm,10 mmol) and phosphorus 
oxychloride (3.06 gm, 20 mmol) was refluxed for 4 hrs on a steam bath . After cooling, the reaction mixture was 
poured carefully onto crushed ice. The solid that separated was filtered off, washed well for several times with 
water, dried and crystallized from ethanol to give pale brown crystals.  
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M.p. 170-172 °C, yield 80 %; IR (cm
-1
): 1741-1697 (2CO), 1590 (C=N), 710 (C-Cl); Ms: m/z 385 (M
·+
), 386 
(M
+
+1); 
1
H NMR (DMSO-d6) δ: 7.46-8.29 (m,12H, Ar-H); Anal. Calcd. For C22H12ClN3O2 (Mol.wt.385): C, 
68.49; H, 3.14; N, 10.89, Found: C, 68.29; H, 3.11; N, 11.00%.  
3.1.4. 2-[4-(4-Methoxyphthalazin-1-yl)-phenyl]-isoindole-1,3-dione (4)  
A solution of Compound 3 (3.85 gm,10 mmol) in methanol (30 mL) containing sodium methoxide (0.54 gm,10 
mmol) was refluxed for 6 hrs. After cooling, the reaction mixture was poured onto ice/HCl, the solid that 
separated was filtered off and recrystallized from ethanol to give pale yellow crystals.  
M.p. 180-182 °C; yield 70 %; IR (cm
-1
): 2947 (C–H aliphatic), 1740-1703 (2CO), 1595 (C=N); Ms: m/z 381 
(M
·+
); 
1
H NMR (DMSO-d6) δ: 3.72 (s,1H,-OCH3), 6.69-8.13 (m,12H, Ar-H); 
13
C NMR (DMSO-d6) δ: 179.21, 
163.22, 144.31, 138.20, 133.11,132.32,132.10, 132.01, 128.61,127.21, 127.42, 126.21, 121.01, 120.91,119.10, 
56.41; Anal. Calcd. For C23H15N3O3 (Mol.wt.381): C 72.43, H 3.96, N 11.02, Found: C 72.33, H 3.93, N 11.12 %.  
3.1.5. 2-[4-(Tetrazolo[5,1-a]phthalazin-6-yl)-phenyl]-isoindole-1,3-dione (5)  
Sodium azide (0.65 gm,10 mmol) was added to a solution of chlorophtha- lazine 3 (3.85 gm,10 mmol) in DMSO 
(20 mL) and all was heated under reflux for 2 hrs .Then, the reaction mixture was cooled, poured onto ice.The 
separated solid was filtered off and recrystallized from ethanol to give pale yellow crystals. 
 M.p. 220-222 °C; yield 55%; IR (cm
-1
): 1708-1698 (2CO), 1597(C=N); Ms: m/z 392 (M
·+
), 393 (M
+1
);
 1
H NMR 
(DMSO-d6) δ: 7.69-8.13 (m, 12H, Ar-H); Anal. Calcd.For C22H12N6O2 (Mol.wt.392): C, 67.34; H, 3.08; N, 21.42; 
Found: C, 67.50; H, 3.01; N, 21.39%. 
3.1.6. 2-{4-[4-[(2-Hydroxy-ethylamino)phthalazin-1-yl]-phenyl}-isoindole-1,3-dione (6)  
Ethanol amine (0.61 gm, 10 mmol) was added to a solution of compound 3 (3.85 gm, 10 mmol) in dioxane (40 mL). 
Whole mixture was heated under reflux for 20 hrs. The solid that separated after concentration was triturated with 
water, filtered off and crystallized from ethanol to give yellow crystals.  
M.p. 260-262 °C, yield 60 % ; IR (cm
-1
): 3461-3154 (OH,NH), 2995 (C–H aliphatic), 1706-1668 (2CO) ,1594 (C=N); 
Ms: m/z 410 (M
·+
); 
1
H NMR (DMSO-d6) δ: 2.19 (s, 1H, OH exchangeable), 3.20-3.25 (t, 2H, CH2), 4.9 (s, 1H, NH), 
7.46-8.15 (m, 12H, Ar-H); 
13
C NMR (DMSO-d6) δ: 166.01, 163.21, 143.11, 138.2, 133.12, 132.01,132.21, 132.30, 
127.41, 127.22 , 127.01, 120.91, 119.01, 116.01, 64.51, 54.91;Anal. Calcd. For C24H18N4O3 (Mol.wt.410): C, 70.23; 
H, 4.42; N, 13.65, Found: C, 70.33; H, 4.32; N, 13.69%.  
3.1.7.6-[4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-phenyl]-2,3-dihydro-1H-imi-dazo[2,1-a]phthalazin-4-ylium 
chloride (7) 
A mixture of compound 6 (4.1 gm, 1o mmol) and SOCl2 (1.18 gm,10 mmol) was refluxed for 2 hr in the 
presence of dry benzene. The solid that separated upon cooling was filtered off and recrystallized from ethanol to 
give pale yellow crystals. 
M.p. 280-282 °C; yield 50 %; IR (cm
-1
): 3250 cm
-1 
(NH),1747-1665 (2CO),1596 (C=N); Ms: m/z 428 (M
·+
);
 1
H 
NMR (DMSO-d6) δ: 6.32 (s, 1H, NH exchangeable), 3.17-3.23 (t, 2H, CH2), 7.46-8.13 (m,12H, Ar-H); Anal. 
Calcd. For C24H17ClN4O2 (Mol.wt.428): C, 67.21; H, 4.00; N, 13.06, Found: C, 67.31; H, 4.31; N 12.99%. 
3.1.8. 2-[4-(2,3-Dihydro-imidazo[2,1-a]phthalazin-6-yl)-phenyl]-isoindole-1,3-dione (8) 
 A compound 7 (4.28 gm, 10 mmol) was dissolved in 10% K2CO3 then extracted the solution with chloroform. 
Evaporation of the solvent gave free base 8 which was recrystallized from ethanol to give light brown crystals.  
M.p. 300-302 °C; yield 70 %; IR (cm
-1
): 1747-1665 (2CO), 1602 (C=N); Ms: m/z 392 (M·+); Anal. Calcd. For 
C24H16N4O2 (Mol.wt.392): C, 73.46; H, 4.11; N, 14.28, Found: C, 73.51; H, 4.12; N 14.38%. 
3.1.9   2-[4-(4-Mercaptophthalazin-1-yl)-phenyl]-isoindole-1,3-dione (9) 
An equimolar amount of 3 (3.85 gm,10 mmol) and thiourea (0.76 gm,10 mmol) in ethanol (20 mL) containing 
10 mmol of sodium ethoxide was heated under reflux for 6 hrs. The reaction mixture was poured onto ice/water, 
then, acidified with acetic acid.The solid product which formed was collected by filteration, dried and 
crystallized from ethanol to give yellow crystals.    M.p. 230-232 °C; yield 56 %; IR (cm
-1
): 
2660 cm
-1 
(SH), 1747-1665 (2CO), 1596 (C=N); Ms: m/z 384 (M
+
+1);
 1
H NMR (DMSO-d6) δ: 9.81 (s, 1H, SH, 
exchangeable), 7.46-8.13 (m, 12H, Ar-H); Anal. Calcd. For C22H13N3O2S (Mol.wt.383): C, 68.91; H, 3.42; N, 
10.96, Found: C, 68.81; H, 3.49; N 10.99%.  
3.1.10.   2-[4-(3-Phenyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-phenyl]-isoindole-1,3-dione (10)  
A mixture of 3 (3.85 gm,10 mmol) and benzoylhydrazine (1.36 gm ,10 mmol) in n-butanol (30 mL) was refluxed 
for 50 hrs. The solid that separated after concentration and cooling was filtered off, and crystallized from ethanol 
to give yellow crystals.           M.p. 
230-232 °C; yield 65 %; IR (cm
-1
): 1704-1668 (2CO), 1597 (C=N); Ms: m/z 468 (M
+
+1); Anal. Calcd. For 
C29H17N5O2 (Mol.wt.467): C, 74.52; H, 3.67; N, 14.98, Found: C, 74.81; H, 3.70; N, 15.01%. 
3.1.11. {4-[4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-phenyl]phthalazin-1-yl amino}-acetic acid (11)  
Compound 3 (3.85 gm,10 mmol) and glycine (0.75 gm,10 mmol) in pyridine containing few drops of water (4 
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mL) was heated under reflux for 3 hrs. The reaction mixture poured onto ice/HCl. The solid that separated was 
filtered off, washed with water and crystallized from acetic acid to give pale yellow crystals.  
M.p. 235-237 °C, yield 65 %; IR (cm
-1
): 3462-3151 (OH, NH), 2996 (C-H aliphatic) ,1703-1669 (CO), 1594 
(C=N); Ms: m/z 425 (M
+
+1); 
1
H NMR (DMSO-d6) δ 12.84 (s, 1H, OH exchangeable), 8.29 (s, 1H, NH 
exchangeable), 2.5(s, 2H, CH2), 7.28-8.27 (m, 12H, Ar-H); Anal. Calcd. For C24H16N4O4 (Mol.wt.424): C, 67.92; 
H, 3.80, N, 13.20; Found: C, 67.99; H, 3.75; N 13.30%. 
3.1.12. 2-[4-[3-Oxo-2,3-dihydro-imidazo[2,1-a]phthalazin-6-yl)-phenyl]- 
isoindole-1,3-dione (12) 
Acid 11 (4.24 gm, 10 mmol) in acetic anhydride (15 ml) was refluxed for 2 hrs. After cooling, the reaction 
mixture poured onto ice. The solid that separated filtered off, washed with water and crystallized from ethanol to 
give pale yellow crystals. M.p. 190-192 °C; yield 50 %; IR (cm
-1
): 1708 -1700 (2C=O), 1596 (C=N); Ms: m/z 
407 (M
+
+1); Anal. Calcd. For C24H14N4O3 (Mol.wt.406): C, 70.93; H, 3.47; N, 13.79, Found: C, 71.01; H, 3.37; 
N 13.19%. 
3.1.13. 2-[4-(7-Oxo-7H-6,6a,12-triaza-benzo[a]anthracen-5-yl)-phenyl]-isoindole-1,3-dione (13)  
In a fusion tube provided with an air condenser, a mixture of 3 (3.85 gm,10 mmol) and anthranilic acid (1.37 gm ,10 
mmol) was heated in an oil bath at 190-191
◦
C for 2 h. Then the mixture was cooled (to room temperature) and 
poured into 40 mL of cold water. The obtained solid product was collected and recrystallized from benzene to give 
yellow crystals.  
M.p. 220-222 °C; yield 69 %; IR (cm
-1
): 1720-1700 (2CO), 1594 (C=N); Ms: m/z 468 (M
·+
); 
1
H NMR (DMSO-d6) δ 
7.44-7.99 (m, 16H, Ar-H); 
13
C-NMR (DMSO-d6) δ: 170.23, 164.32, 163.21, 155.62, 152.32, 140.52, 133.41, 133.21, 
132.31, 132.01, 130.91, 130.01,  129.20, 129.10, 128.81, 128.62, 127.41, 127.11, 127.01, 126.82, 126.01, 122.12, 
120.51; Anal. Calcd.For C29H16N4O3 (Mol.wt.468): C, 74.35; H, 3.44; N, 11.96, Found: C, 74.45; H, 3.59; N 11.82%. 
3.1.14. 3- or 4-{4-[4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-phenyl]phthalazin-1-ylamino}-benzoic acid (14a,b)  
 A compound 3 (3.85 gm,10 mmol) and amino acid (1.37 gm ,10 mmol) of namely, m-amino benzoic acid or p-
amino benzoic acid were fused into oil bath at 175 °C for 4 hrs. After cooling, water was added and the solid 
obtained filtered off and recrystallized from proper solvent to give 14a,b.  
 M.p. for 14a, 14b 275°C, 200 °C respectively; yield 70, 81 %; IR (cm
-1
): 3492-3117 (OH, NH), 1721-1696 
(2CO), 1603 (C=N); Ms: 488 (M
+
+2); 
1
H NMR (DMSO-d6) δ: 12.85 (s, 1H, OH exchangeable), 7.96 (s, 1H, NH 
exchangeable), 7.41-8.06 (m, 16H, Ar-H); Anal. Calcd. For C29H18N4O4: (Mol.wt.486) C, 71.60; H, 3.73; N, 
11.52, Found: C, 71.52; H, 3.63; N, 11.72%. 
 3.1.15. General procedure for synthesis of (15a-d)  
An equimolar amount of chlorophthalazine 3 (3.85 gm,10 mmol) and      o-phenylene diamine, p-phenylene 
diamine, o-amino phenol or p-amino phenol in benzene (40mL) was heated under reflux for 5 hrs; then the 
reaction mixture was concentrated by evaporation . The solid that obtained was crystallized from ethanol to give 
(15a-d) respectively 
3.1.15.1. 2-{4-[4-(2-Aminophenylamino)phthalazin-1-yl]-phenyl}-isoindole-1,3 -dione (15a)  
Pale yellow crystals; M.p. 230-232 °C; yield 70 %; IR (cm
-1
): 3405-3158 (NH, NH2), 1707-1700(2CO), 1595 
(C=N); 
1
H NMR (DMSO-d6) δ: 12.85 (s, 1H, NH exchangeable), 8.30 (s, 1H, NH2 exchangeable), 6.40-8.27 
(m,16H, Ar-H); 
13
C NMR (DMSO-d6) δ: 166.01, 163.21, 143.01, 138.21, 133.31, 133.01, 132.31, 
132.11,132.01,127.41,127.21, 127.01, 120.90, 119.30, 119.01, 116.01, 115.90; Ms: m/z 458 (M
+
+1); Anal. 
Calcd. For C28H19N5O2 (Mol.wt.457): C, 73.51; H, 4.19; N, 15.31; Found: C, 73.61; H, 4.27; N, 14.98%. 
3.1.15.2. 2-{4-[4-(4-Amino-phenylamino)phthalazin-1-yl]-phenyl}-isoindole-1,3-dione (15b)  
Pale yellow crystals; M.p. 210-212°C; yield 65 %; IR (cm
-1
): 3396-3155 (NH, NH2), 1705-1698 (2CO), 1593 
(C=N); Ms: 458 (M
+
+1); Anal. Calcd. For C28H19N5O2 (Mol.wt.457): C, 73.51; H, 4.19; N, 15.31, Found : C, 
73.70; H, 4.22; N, 15.11%. 
 3.1.15.3. 2-{4-[4-(2-Hydroxyl-phenylamino)phthalazin-1-yl]-phenyl}-isoindole -1,3-dione (15c)  
 Brown crystals; M.p. 280-282 °C; yield 68 %; IR (cm
-1
): 3374-3202 (NH, OH), 1743-1705(2CO), 1596 (C=N); 
Ms: m/z 458 (M
·+
); 
1
H NMR (DMSO-d6) δ: 5.21 (s, 1H, OH phenol exchangeable),4.32 (s, 1H, NH 
exchangeable), 7.41-8.06 (m, 16H, Ar-H); Anal. Calcd. For C28H18N4O3 (Mol.wt.458): C, 73.35; H, 3.96; N, 
12.22 Found : C, 73.45; H, 3.99; N, 12.42%. 
3.1.15.4. 2-{4-[4-(4-Hydroxyl-phenylamino)phthalazin-1-yl]-phenyl}-isoindole -1,3-dione (15d)  
Brown crystals; M.p. 230-232 °C ; yield 75 %; IR (cm
-1
): 3374-3102 (NH, OH), 1743-1705(2CO), 1596 (C=N); 
Ms: m/z 458 (M
·+
); Anal. Calcd. For C28H18N4O3 (Mol.wt.458): C, 73.35; H, 3.96; N, 12.22, Found: C, 73.46; H, 
3.85; N, 12.41%. 
3.1.16 2-(4-Benzo[4,5]imidazo[2,1-a]phthalazin-5-yl-phenyl)-isoindole-1,3-dione (16) 
In a fusion tube provided with an air condenser, Compound 15a and 15c was heated in sand bath at 285-290ºC for 2 
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h. Then, it was cooled (to room temperature) and 30 mL of cold water was added. The obtained solid product was 
collected and recrystallized from ethanol to give yellow crystals. M.p. 300-302 °C; yield 75 %; IR (cm
-1
): 1743-1705 
(2CO), 1601 (C=N); Ms: m/z 441 (M
·
+1); Anal. Calcd. For C28H16N4O2 (Mol.wt.440): C, 76.35; H, 3.66; N, 12.72, 
Found: C, 76.44; H, 3.76; N, 12.64%. 
3.1.17. 2-[4-(2-Ethyl-1-oxo-3-thioxo-2,3-dihydro-1H-2,4,10,10a-tetrazaph enanthren-9-yl)-phenyl]-isoindole-
1,3-dione (18) 
A mmoniumthiocyanate (0.71 gm, 10 mmol) in dry acetone was added to a stirred solution of chlorophthalazine 
3 (3.85 gm, 10 mmol) in dry acetone. The reaction mixture was stirred for 1 h at room temperature. Ammonium 
chloride was precipitated during the progress of the reaction. After filtration of the ammonium chloride, ethyl 
isocyanate 10 mmol was added to the filtrate. The reaction mixture was heated under reflux for 30 min. The solid 
product that separated after cooling was crystallized from ethanol to give yellow crystals. 
 M.p. 120-122 °C, yield 56 %; IR (cm
-1
): 2950 (C–H aliphatic), 1710 -1699 (2CO); Ms: m/z 479 (M
·+
);
 1
H NMR 
(DMSO-d6) δ: 1.32 (t, 3H, CH3), 3.22 (q, 2H, CH2), 7.59-8.13 (m, 12H, Ar-H); Anal. Calcd. For C26H17N5O3S 
(Mol.wt.479): C, 65.12; H, 3.57; N, 14.61, Found: C, 65.01; H, 3.65; N 14.81%.  
3.1.18. General procedure for synthesis of (19a-c)  
A solution of 3 (3.85 gm,10 mmol) and primary amines (10 mmol) namely, benzylamine, p-amino benzophenone or 
hydrazine hydrate in n-butanol (40 mL) was heated under reflux for 6hrs. The solid that separated after concentration 
was recrystallized from proper solvent to give 19a-c. 
3.1.18.1. 2-[4-(4-Benzylaminophthalazin-1-yl)-phenyl]-isoindole-1,3-dione (19a)  
Yellow crystals; M.p. 160-162 °C ; yield 60 %; IR (cm
-1
): 3422 (NH), 2930 (C–H aliphatic), 1743-1704 (2CO), 1599 
(C=N); Ms: m/z 458 (M
+
+2); 
1
H NMR (DMSO-d6) δ: 7.96 (s, 1H, NH exchangeable), 7.06-8.13 (m, 16H, Ar-H); 
Anal. Calcd. For C29H20N4O2 (Mol.wt.456): C, 76.30; H, 4.42; N, 12.27, Found: C, 76.01; H, 4.62; N 12.41%. 
3.1.18.2. 2-[4-(4-Benzoylphenylaminophthalazin-1-yl)-phenyl]-isoindole-1,3-dione (19b) 
Yellow crystals; M.p. 200-202 °C; yield 66 %; IR (cm
-1
): 3396 (NH), 1705-1689 (2CO), 1595 (C=N); Ms: m/z 546 
(M
·+
); 
1
HNMR (DMSO-d6) δ 7.32 (d, 1H, NH, exchangeable), 7.06-8.13 (m, 16H, Ar-H); Anal. Calcd.For 
C35H22N4O3 (Mol.wt.546): C, 76.91; H, 4.06; N, 10.25, Found : C, 76.99; H, 4.23; N, 10.15% .  
3.1.18.3. 2-[4-(4-Hydrazinophthalazin-1-yl)-phenyl]-isoindole-1,3-dione (19c) 
Pale yellow crystals ; M.p. 170-172 °C, yield 70 % ; IR (cm
-1
): 3424 -3159 (NH, NH2), 17851-1664 (2CO) ,1596 
(C=N); Ms: m/z 384(M
+
+3);
 1
H NMR (DMSO-d6) δ: 7.85 (d, 1H, NH exchangeable), 8.30 (s, 1H, NH2 
exchangeable),7.06-8.13 (m, 12H, Ar-H); Anal. Calcd. For C22H15N5O2 (Mol.wt.381): C, 69.28; H, 3.96; N, 18.36, 
Found: C, 69.48; H, 3.86; N, 18.56%. 
3.1.19. 2-[4-(3- methyl-[1,2,4]triazolo-[3,4-a]phthalazin-6-yl) phenyl]- isoindole -1,3-dione (20)  
Hydrazinophthalazine 18c (3.81 gm,10 mmol) in AcOH (30 mL) was heated under reflux for 8 hrs.The solid that 
separated after concentration and cooling was recrystallized from ethanol to give yellow crystals. M.p.200-202 °C; 
yield 65 %; IR (cm
-1
): 2950 (C–H aliphatic), 1764-1704 (2CO), 1596 (C=N); Ms: m/z 406 (M
+
+1);
 1
H NMR 
(DMSO-d6) δ: 2.35 (m, 3H, CH3), 7.46-8.13 (m, 12H, Ar-H); Anal. Calcd. For C24H15N5O2 (Mol.wt.405): C, 71.10; 
H, 3.73; N, 17.27, Found : C, 71.32; H, 3.63; N, 17.47%.  
3.1.20. 2-{4-[4-(N-Benzylidene-hydrazino)phthalazin-1-yl]-phenyl}-isoindole-1,3-dione (21) 
A mixture of 18c (3.81 gm,10 mmol) and benzaldehyde (1.06 gm,15 mmol) was heated under reflux for 4 hrs. in 
n-butanol (40 mL) . The solid that separated after concentration and cooling was recrystallized from 
dimethylform- amide/water to give pale yellow crystals.  
M.p.210-212 °C; yield 69 %; IR (cm
-1
): 3437 (NH), 1750-1664 (2CO); Ms: m/z 469 (M
·+
); Anal. Calcd. For 
C29H19N5O2 (Mol.wt.469): C, 74.19; H, 4.08; N, 14.92, Found: C, 74.23; H, 4.11; N, 14.85%. 
3.2. Pharmacology 
Material and methods 
3.2.1. Cell Culture 
Human hepatocarcinoma cell line (HepG2), purchased from ATCC, USA, was used to evaluate the cytotoxic 
effect of the tested extracts. Cells were routinely cultured in DMEM (Dulbeco’s Modified Eagle’s Medium), 
which was supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, containing 100 units/ml 
penicillin G sodium, 100 units/ml streptomycin sulphate, and 250 mg/ml amphotericin B. Cells were maintained 
at sub-confluency at 37ºC in humidified air containing 5% CO2. For sub-culturing, monolayer cells were 
harvested after trypsin/EDTA treatment at 37°C. Cells were used when confluence had reached 75%. Tested 
samples were dissolved in dimethyl sulphoxide (DMSO), and then diluted serially in the assay to begin with the 
mentioned concentration. All cell culture material was obtained from Cambrex BioScience (Copenhagen, 
Denmark). All chemicals were from Sigma/Aldrich, USA, except mentioned. All experiments were repeated 
three times, unless mentioned. 
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3.2.2. Anti-tumor activity  
Cytotoxicity of tested samples was measured against HepG2 cells using the MTT Cell Viability Assay. MTT (3-
[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) assay is based on the ability of active 
mitochondrial dehydrogenase enzyme of living cells to cleave the tetrazolium rings of the yellow MTT and form 
a dark blue insoluble formazan crystals which is largely impermeable to cell membranes, resulting in its 
accumulation within healthy cells. Solubilization of the cells results in the liberation of crystals, which are then 
solubilized. The number of viable cells is directly proportional to the level of soluble formazan dark blue color. 
The extent of the reduction of MTT was quantified by measuring the absorbance at 570 nm (Hansen et al, 1989).  
3.2.2.1 Reagents preparation:  
1. MTT solution: 5mg/ml of MTT in 0.9%NaCl. 
2. Acidified isoprpanol: 0.04 N HCl in absolute isopropanol. 
3.2.2.2 Procedure 
Cells (0.5X10
5
 cells/ well), in serum-free media, were plated in a flat bottom 96-well microplate, and treated 
with 20µl of different concentrations of the tested sample for 48 h at 37 ºC, in a humidified 5% CO2 atmosphere. 
After incubation, media were removed and 40 µl MTT solution / well were added and incubated for an 
additional 4 h. MTT crystals were solubilized by adding 180 µl of acidified isopropanol / well and plate was 
shacked at room temperature, followed by photometric determination of the absorbance at 570 nm using 
microplate ELISA reader.Triplicate repeats were performed for each concentration and the average was 
calculated. Data were expressed as the percentage of relative viability compared with the untreated cells 
compared with the vehicle control, with cytotoxicity indicated by <100% relative viability [24]. 
3.2.2.3 Calculation  
Percentage of relative viability was calculated using the following equation: 
[Absorbance of treated cells/ Absorbance of control cells)] X 100 
Then the half maximal inhibitory concentration (IC50) was calculated from the equation of the dose response 
curve. 
3.2.2.4 Results 
Anti-tumor activity 
Using MTT assay, the effect of the samples on the proliferation of Hep-G2 cells were studied after 48 h of 
incubation. As shown in figure 1, the treatment of Hep-G2 cells with the samples showed different cytotoxic 
effect against Hep-G2. 
Presence of amino acid, triazine and hydrazine moieties attached to phthalazine enhances the antitumor activity. 
So for samples 11, 18 and 19c they showed the most potent cytotoxic effect concluded from their IC50 values 
217.4, 240.3 and 234.5 µg/ml respectively. For samples 13, 14b, 19a, 19b and 21 they showed weak cytotoxic 
effect concluded from their IC50 values of 327.3, 417.5, 442.7, 440.7 and 314.2 µg/ml respectively. 
For all other samples 3, 4, 5, 9, 10, 15a and 15b they did not show any cytotoxic effect concluded from their 
IC50 values > 500 µg/ml. Fig.3: showed cytotoxic effect of different samples against Hep-G2 cells using MTT 
assay (n=4), data expressed as the mean value of cell viability (% of control) ± S.E. 
And  Fig. 4 showed a comparison of the IC50 values between different samples. 
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Fig.3: Cytotoxic effect of different samples against Hep-G2 cells using MTT assay (n=4), data expressed as the 
mean value of cell viability (% of control) ± S.E. 
 
Fig.4: Calculated IC50 of different samples against Hep-G2 cells using MTT assay.  
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